Reprogramming of Amino Acid Metabolism Differs between Community-Acquired Pneumonia and Infection-Associated Exacerbation of Chronic Obstructive Pulmonary Disease

Amino acids and their metabolites are key regulators of immune responses, and plasma levels may change profoundly during acute disease states. Using targeted metabolomics, we evaluated concentration changes in plasma amino acids and related metabolites in community-acquired pneumonia (CAP, n = 29; compared against healthy controls, n = 33) from presentation to hospital through convalescence. We further aimed to identify biomarkers for acute CAP vs. the clinically potentially similar infection-triggered COPD exacerbation (n = 13). Amino acid metabolism was globally dysregulated in both CAP and COPD. Levels of most amino acids were markedly depressed in acute CAP, and total amino acid concentrations on admission were an accurate biomarker for the differentiation from COPD (AUC = 0.93), as were reduced asparagine and threonine levels (both AUC = 0.92). Reduced tryptophan and histidine levels constituted the most accurate biomarkers for acute CAP vs. controls (AUC = 0.96, 0.94). Only kynurenine, symmetric dimethyl arginine, and phenylalanine levels were increased in acute CAP, and the kynurenine/tryptophan ratio correlated best with clinical recovery and resolution of inflammation. Several amino acids did not reach normal levels by the 6-week follow-up. Glutamate levels were reduced on admission but rose during convalescence to 1.7-fold above levels measured in healthy control. Our data suggest that dysregulated amino acid metabolism in CAP partially persists through clinical recovery and that amino acid metabolism constitutes a source of promising biomarkers for CAP. In particular, total amino acids, asparagine, and threonine may constitute plasma biomarker candidates for the differentiation between CAP and infection-triggered COPD exacerbation and, perhaps, the detection of pneumonia in COPD.

[1]  B. Wei,et al.  The diagnostic value of homocysteine for the occurrence and acute progression of chronic obstructive pulmonary disease , 2020, BMC Pulmonary Medicine.

[2]  T. Ishida,et al.  Diagnostic markers for community-acquired pneumonia , 2020, Annals of translational medicine.

[3]  S. C. Huang,et al.  Carbohydrate and Amino Acid Metabolism as Hallmarks for Innate Immune Cell Activation and Function , 2020, Cells.

[4]  J. Rello,et al.  Burden of Community-Acquired Pneumonia and Unmet Clinical Needs , 2020, Advances in Therapy.

[5]  M. Akmatov,et al.  Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia , 2019, Journal of Translational Medicine.

[6]  T. Tábi,et al.  Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD , 2019, Respiratory Research.

[7]  K. Müller-Vahl,et al.  Kynurenine Is a Cerebrospinal Fluid Biomarker for Bacterial and Viral Central Nervous System Infections. , 2019, The Journal of infectious diseases.

[8]  Hamed Kazemi Shariat Panahi,et al.  Microorganisms, Tryptophan Metabolism, and Kynurenine Pathway: A Complex Interconnected Loop Influencing Human Health Status , 2019, International journal of tryptophan research : IJTR.

[9]  K. Patel,et al.  Respiratory Chlamydia Infection Induce Release of Hepoxilin A3 and Histamine Production by Airway Neutrophils , 2018, Front. Immunol..

[10]  A. Mangoni,et al.  Systemic concentrations of asymmetric dimethylarginine (ADMA) in chronic obstructive pulmonary disease (COPD): state of the art , 2018, Amino Acids.

[11]  Yan Zhang,et al.  Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity , 2018, Critical Care.

[12]  A. Mangoni,et al.  Increased kynurenine plasma concentrations and kynurenine-tryptophan ratio in mild-to-moderate chronic obstructive pulmonary disease patients. , 2018, Biomarkers in medicine.

[13]  M. Christ-Crain,et al.  Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2017, Lung.

[14]  M. Christ-Crain,et al.  Activation of the tryptophan/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study , 2017, Clinical chemistry and laboratory medicine.

[15]  Bernard Walther,et al.  The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age , 2017, PloS one.

[16]  M. Christ-Crain,et al.  Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia , 2017, Respiratory Research.

[17]  I. Horváth,et al.  L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker , 2016, COPD.

[18]  J. Gostner,et al.  Immune activation and inflammation increase the plasma phenylalanine-to-tyrosine ratio , 2013 .

[19]  E. Kontny,et al.  Taurine and inflammatory diseases , 2012, Amino Acids.

[20]  K. Chida,et al.  Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia. , 2011, The Journal of infection.

[21]  K. Takehana,et al.  Regulatory Roles of Amino Acids in Immune Response , 2009 .

[22]  J. Menetski,et al.  Identification of novel monosodium urate crystal regulated mRNAs by transcript profiling of dissected murine air pouch membranes , 2008, Arthritis research & therapy.

[23]  N. Mauras,et al.  Corticosteroids increase glutamine utilization in human splanchnic bed. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[24]  G. Edsall,et al.  Effects of malnutrition on the immune response in humans: a review. , 1975, Tropical diseases bulletin.

[25]  W. Beisel Interrelated changes in host metabolism during generalized infectious illness. , 1972, The American journal of clinical nutrition.

[26]  W. Beisel,et al.  Tryptophan metabolism during infectious illness in man. , 1970, Journal of Infectious Diseases.

[27]  A. Schauer,et al.  Increased Histidine Decarboxylase Activity of Rat Lung in Endotoxin Shock , 1966, Nature.